Free Trial

Clover Health Investments (CLOV) Competitors

Clover Health Investments logo
$4.20
+0.08 (+1.94%)
(As of 11/1/2024 ET)

CLOV vs. NFH, DGNR, SKLZ, VOYA, JXN, BNRE, ESNT, BWIN, ACT, and FG

Should you be buying Clover Health Investments stock or one of its competitors? The main competitors of Clover Health Investments include New Frontier Health (NFH), Dragoneer Growth Opportunities (DGNR), Skillz (SKLZ), Voya Financial (VOYA), Jackson Financial (JXN), Brookfield Reinsurance (BNRE), Essent Group (ESNT), The Baldwin Insurance Group (BWIN), Enact (ACT), and F&G Annuities & Life (FG).

Clover Health Investments vs.

New Frontier Health (NYSE:NFH) and Clover Health Investments (NASDAQ:CLOV) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, valuation, risk, earnings, media sentiment, dividends, profitability, community ranking and analyst recommendations.

New Frontier Health has a beta of 0.13, suggesting that its stock price is 87% less volatile than the S&P 500. Comparatively, Clover Health Investments has a beta of 2.03, suggesting that its stock price is 103% more volatile than the S&P 500.

New Frontier Health has higher earnings, but lower revenue than Clover Health Investments. New Frontier Health is trading at a lower price-to-earnings ratio than Clover Health Investments, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
New Frontier Health$346.44M4.55-$73.26M-$0.43-27.79
Clover Health Investments$2.09B1.00-$213.36M-$0.27-15.56

In the previous week, Clover Health Investments had 4 more articles in the media than New Frontier Health. MarketBeat recorded 4 mentions for Clover Health Investments and 0 mentions for New Frontier Health. Clover Health Investments' average media sentiment score of 0.46 beat New Frontier Health's score of 0.00 indicating that Clover Health Investments is being referred to more favorably in the news media.

Company Overall Sentiment
New Frontier Health Neutral
Clover Health Investments Neutral

Clover Health Investments has a consensus price target of $4.00, suggesting a potential downside of 4.76%. Given Clover Health Investments' higher probable upside, analysts plainly believe Clover Health Investments is more favorable than New Frontier Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
New Frontier Health
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Clover Health Investments
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

19.8% of Clover Health Investments shares are held by institutional investors. 22.3% of Clover Health Investments shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

New Frontier Health has a net margin of 0.00% compared to Clover Health Investments' net margin of -7.30%. New Frontier Health's return on equity of 0.00% beat Clover Health Investments' return on equity.

Company Net Margins Return on Equity Return on Assets
New Frontier HealthN/A N/A N/A
Clover Health Investments -7.30%-36.55%-15.05%

Clover Health Investments received 19 more outperform votes than New Frontier Health when rated by MarketBeat users. However, 66.67% of users gave New Frontier Health an outperform vote while only 38.89% of users gave Clover Health Investments an outperform vote.

CompanyUnderperformOutperform
New Frontier HealthOutperform Votes
2
66.67%
Underperform Votes
1
33.33%
Clover Health InvestmentsOutperform Votes
21
38.89%
Underperform Votes
33
61.11%

Summary

Clover Health Investments beats New Frontier Health on 10 of the 16 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CLOV vs. The Competition

MetricClover Health InvestmentsHospital & medical service plans IndustryMedical SectorNASDAQ Exchange
Market Cap$2.09B$66.71B$5.50B$8.53B
Dividend YieldN/A1.55%5.13%4.14%
P/E Ratio-15.5518.24116.1015.23
Price / Sales1.000.731,496.2597.74
Price / CashN/A9.4139.7434.10
Price / Book7.125.734.775.07
Net Income-$213.36M$3.04B$119.06M$225.46M
7 Day Performance7.14%2.70%0.80%0.37%
1 Month Performance16.99%0.88%5.65%3.57%
1 Year Performance315.84%62.77%36.75%29.43%

Clover Health Investments Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CLOV
Clover Health Investments
1.4445 of 5 stars
$4.20
+1.9%
$4.00
-4.8%
+361.1%$2.09B$2.09B-15.55552Upcoming Earnings
NFH
New Frontier Health
N/A$11.95
flat
N/A+0.0%$1.58B$346.44M-27.793,309High Trading Volume
DGNR
Dragoneer Growth Opportunities
N/A$9.26
flat
N/A+0.0%$638.94MN/A0.00147,000
SKLZ
Skillz
2.2146 of 5 stars
$5.73
+1.8%
$10.67
+86.2%
+9.7%$99.87M$150.11M-2.19240News Coverage
VOYA
Voya Financial
4.8469 of 5 stars
$80.92
+1.5%
$85.27
+5.4%
+18.0%$7.96B$7.35B10.669,000Upcoming Earnings
Dividend Announcement
JXN
Jackson Financial
3.2812 of 5 stars
$102.01
+3.8%
$80.33
-21.2%
+163.5%$7.78B$4.41B3.773,840Upcoming Earnings
Short Interest ↓
BNRE
Brookfield Reinsurance
N/A$53.40
-1.4%
N/A+73.8%$7.77B$9.35B184.144,000
ESNT
Essent Group
4.6937 of 5 stars
$61.19
+1.2%
$66.50
+8.7%
+12.4%$6.50B$1.11B8.86350Dividend Announcement
News Coverage
Gap Down
BWIN
The Baldwin Insurance Group
2.685 of 5 stars
$50.68
+0.9%
$47.67
-5.9%
N/A$5.96B$1.30B-63.354,000Upcoming Earnings
ACT
Enact
N/A$34.55
-0.3%
$35.00
+1.3%
+17.1%$5.43B$1.19B8.29500Upcoming Earnings
High Trading Volume
FG
F&G Annuities & Life
3.3062 of 5 stars
$41.59
+0.7%
$45.67
+9.8%
+31.3%$5.24B$4.50B16.841,165Upcoming Earnings
Short Interest ↑
News Coverage

Related Companies and Tools


This page (NASDAQ:CLOV) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners